Thermo Fisher Scientific Inc (TMO)
Thermo Fisher Scientific Inc (TMO) carries a ŷRobot AI score of 70 out of 100. The model's fair value estimate is $778.61, 11.2% above the last close of $700.33. The chart signal reads Bearish.
| Metric | TMO |
|---|---|
| AI score | 70 / 100 |
| Chart signal | Bearish |
| Fair value estimate | $778.61 |
| Upside to fair value | 11.2% |
| Previous close | $700.33 |
| P/E | 36.60 |
| Price / sales | 5.54 |
| Market cap | $259.15B |
| EPS | 18.96 |
| Revenue growth | -0.2% |
| 1-year price change | 6.6% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about TMO
Is TMO overvalued or undervalued right now?
As of Oct 22, 2026, ŷRobot's fair-value model estimates Thermo Fisher Scientific Inc (TMO) at $778.61 against a last close of $700.33, implying 11.2% upside to the model's estimate.
Is TMO's chart signal bullish or bearish?
The chart-signal model classifies TMO as Neutral as of Nov 13, 2026, with a signal score of -0.09 on a -1 to 1 scale.
What is TMO's ŷRobot AI score?
TMO scores 70 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is TMO stock expensive on P/E and P/S?
TMO trades at 36.6 times earnings and 5.5 times sales as of Nov 13, 2026.
What does TMO's seasonal forecast show?
ŷRobot's seasonal forecast curve for TMO reads +1.7% at 30 days, +4.2% at 90 days, and +6.6% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is TMO growing?
Thermo Fisher Scientific Inc's revenue growth is -0.2% and free-cash-flow growth is +1.5% on the latest reported figures.
TMO chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.